Iwona Podzielinski MD
Gynecologic Oncology
Gynecologic Oncologist, Fort Wayne, IN
Join to View Full Profile
737 N Detroit StWarsaw, IN 46580
Phone+1 260-436-0800
Fax+1 260-483-1911
Dr. Podzielinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Kentucky College of MedicineFellowship, Gynecologic Oncology, 2012
Indiana University School of MedicineResidency, Obstetrics and Gynecology, 2005 - 2009- Indiana University School of MedicineClass of 2005
Certifications & Licensure
MI State Medical License 2024 - 2027
SD State Medical License Active through 2027
OH State Medical License 2020 - 2026
IN State Medical License 2006 - 2025
MN State Medical License 2023 - 2024
KY State Medical License 2009 - 2013
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2012-2013
Publications & Presentations
PubMed
- Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial can...Giorgio Valabrega, Matthew A Powell, Sakari Hietanen, Eirwen M Miller, Zoltan Novak
International Journal of Gynecological Cancer. 2025-01-06 - Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled...Annika Auranen, Matthew A Powell, Vladyslav Sukhin, Lisa M Landrum, Graziana Ronzino
Therapeutic Advances in Medical Oncology. 2024-01-01 - 4 citationsActivity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series.Peter G Rose, Myra Feldman, Iwona Podzielinski, Aaron P Petty, Roberto Vargas
Gynecologic Oncology Reports. 2023-12-01
Press Mentions
Parkview Health Reminding Women to Monitor for Rare, but Dangerous Ovarian CancerSeptember 21st, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
